T-cell interleukin-6 receptor binding in patients with myasthenia gravis

Journal of the Neurological Sciences

Volumn 158, Issue 2, 1998, Pages 215-220

  Bongioanni, Paolo ^a   Ricciardi, Roberta ^a   Romano, Maria Rosaria ^a   Murri, Luigi ^a   Muratorio, Alberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cytokines; Immune response; Interleukin 6; Lymphocytes; Myasthenia gravis; T cells

Indexed keywords

INTERLEUKIN 6 RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE;

ADULT; AGED; BLOOD CELLS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTORS, INTERLEUKIN-6; REFERENCE VALUES; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032581183     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00129-4     Document Type: Article

References (32)

1. Besinger U.A., Toyka K.V., Hömberg M.et al. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology. 33(S10):1983;1316-1321.
2. + lymphocytes. J. Biol. Regul. Homeostatic Agents. 5:1991;23-33.
3. Cohen-Kaminsky S., Delattre R.M., Devergne O. High IL-6 gene expression and production by cultured human thymic epithelial cells from patients with myasthenia gravis. Ann. N.Y. Acad. Sci. 681:1993;97-99.
4. Cohen-Kaminsky S., Devergne O., Delattre R.M. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia. Eur. Cytokine Netw. 4:1993;121-132.
5. Degiannis D., Luke-Gustites D., Mikhail N.et al. Binding of phycoerythrin-conjugated interleukin-6 to in vitro-activated human peripheral blood mononuclear cells-effect of immunosuppressive agents and of a calcium channel blocker. Transplantation. 54:1992;308-312.
6. Dett C.A., Gatanaga M., Ininns E.K.et al. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1β, IL-4, and IL-6 in vitro. J. Immunol. 146:1991;1522-1526.
7. Ding L., Shevach E. IL-10 inhibits mitogen induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:1992;3313-3319.
8. Drachman D.B., Adams R.N., Josifek L.F.et al. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. New Engl. J. Med. 307:1982;769-775.
9. Emilie D., Crevon M.C., Cohen-Kaminsky S. In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. Hum. Pathol. 22:1991;461-468.
10. Engel AG, Sahashi K, Lambert EH, Howard FM. In: Aguayo AJ, Karpati G, editors. Current Topics in Nerve and Muscle Research. Amsterdam: Excerpta Medica, 1979:111-122.
11. Hibi M., Muakami M., Saito M.et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1990;1149-1157.
12. Ihle J.N. Cytokine receptor signalling. Nature. 377:1995;591-594.
13. Kao I., Drachman D.B. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science. 196:1977;527-529.
14. Kishimoto T., Hirano T. Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6:1988;485-499.
15. Lansdorp P.M., Aarden L.A., Calafat J.et al. A growth-factor dependent B-cell hybridoma. Curr. Top. Microbiol. Immunol. 132:1986;105-110.
16. Lotz M., Jirik F., Kabouridis R. BSF-2/IL-6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167:1988;1253-1261.
17. Malefyt R., Haanen J., Spits H. IL-10 and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II MHC expression. J. Exp. Med. 174:1991;915-924.
18. McPherson GA. Kinetic, EBDA, Ligand, Lowry. A Collection of Radioligand Binding Analysis Programs. Amsterdam: Elsevier, 1985.
19. Newsom-Davis J. Autoimmunity in neuromuscular disease. Ann. N. Y. Acad. Sci. 540:1988;25-38.
20. Nicola NA. Guidebook to cytokines and their receptors. Oxford: Sambrook and Tooze Publication at Oxford University Press, 1994.
21. Osserman KE. Myasthenia Gravis. New York: Grune and Stratton, 1958:79-86.
22. Petersen C.M., Davidsen O., Moestrup S.K.et al. Cellular targets and receptors for interleukin-6. II. Characterization of IL-6 binding and receptors in peripheral blood cells and macrophages. Eur. J. Clin. Invest. 20:1990;377-384.
23. Rouveix B., Blin O. Pharmacological basis of immunotherapy in autoimmune diseases. Clin. Neuropharmacol. 16:1993;104-112.
24. Satoh T., Nakamura S., Taga T. Induction of neural differentiation in PC12 cells by B cell stimulatory factor 2/interleukin 6. Mol. Cell Biol. 8:1988;3546-3551.
25. Shimada K., Koh C.S., Yanagisawa N. Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases. Arerugi. 42:1993;934-940.
26. Stahl M., Boulton T.G., Farruggella T. Association and activation of Jak-Tyk kinase by CNTF-LIF-OSM-IL-6β receptor components. Science. 263:1994;92-95.
27. Taga T., Hibi M., Hirata Y. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573-581.
28. Taga T., Kishimoto T. Cytokine receptors and signal transduction. FASEB J. 6:1992;3387-3396.
29. Takenawa J., Kaneko Y., Okumura K.et al. Inhibitory effect of dexamethasone and progesterone in vitro on proliferation of human renal cell carcinomas and effects on expression of interleukin-6 or interleukin-6 receptor. J. Urol. 153:1995;858-862.
30. Toyka K.V., Drachman D.B., Griffin D.E. Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice. New Engl. J. Med. 396:1977;125-131.
31. Yamasaki K., Taga T., Hirata Y. Cloning and expression of the human interleukin-6(BSF-2/IFN beta2) receptor. Science. 241:1988;825-828.
32. Yasukawa K., Hirano T., Watanabe Y.et al. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 6:1987;2939-2945.